Rinatabart: A Novel Anti-FRα Antibody for Targeted Therapy
The new antibody provides the promising method for targeted cancer therapy. This selectively binds the receptor α, an key protein involved in cellular growth and survival. Initial studies demonstrate substantial lowering in tumor volume and improved patient outcomes with this